Myocardial recovery: a focus on the impact of left ventricular assist devices

References

• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012;125(1):e2-220
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2013 update a report from the American Heart Association. Circulation 2013;127(1):e6-245
   PubMed Web of Science ®Google Scholar
• Death: final Data for 2009 National Vital Statistics Reports. Available from: www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_03.pdf
   Google Scholar
• Heart Failure Fact Sheet|Data & Statistics|DHDSP|CDC. Available from: www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_failure.htm
   Google Scholar
• Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348(20):2007-18
   PubMed Web of Science ®Google Scholar
• Butler CR, Jugdutt BI. The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev 2012;17(4-5):615-33
   PubMedGoogle Scholar
• Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirtieth Official Adult Heart Transplant Report—2013; focus theme: age. J Heart Lung Transplant 2013;32(10):951-64
   PubMed Web of Science ®Google Scholar
• Organ Procurement and Transplantation Network Waiting List Data. (2014). Available from: http://optn.transplant.hrsa.gov/data/default.asp
   Google Scholar
• Heart, 2011 SRTR & OPTN Annual Data Report. Available from: http://srtr.transplant.hrsa.gov/annual_reports/2011/flash/05_heart/index.html
   Google Scholar
• Kirklin JK, Naftel DC, Pagani FD, et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012;144(3):584-603. discussion 597 -8
   PubMed Web of Science ®Google Scholar
• Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014;370(1):33-40
   PubMed Web of Science ®Google Scholar
• Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009;208(5):755-61. discussion 761–762
   PubMedGoogle Scholar
• Bartoli CR, Giridharan GA, Litwak KN, et al. Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle. ASAIO J 1992;2010:56(5):410-16
   Google Scholar
• Loor G, Gonzalez-Stawinski G. Pulsatile vs. continuous flow in ventricular assist device therapy. Best Pract Res Clin Anaesthesiol 2012;26(2):105-15
   PubMedGoogle Scholar
• Birks EJ. Molecular changes after left ventricular assist device support for heart failure. Circ Res 2013;113(6):777-91
   PubMedGoogle Scholar
• Birks EJ. Myocardial recovery in patients with chronic heart failure: is it real? J Card Surg 2010;25(4):472-7
   PubMedGoogle Scholar
• Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail 2011;4(2):224-33
   PubMed Web of Science ®Google Scholar
• Kato TS, Chokshi A, Singh P, et al. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail 2011;4(5):546-53
   PubMedGoogle Scholar
• Drakos SG, Kfoury AG, Stehlik J, et al. Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation 2012;126(2):230-41
   PubMedGoogle Scholar
• Mann DL, Burkhoff D. Is myocardial recovery possible and how do you measure it? Curr Cardiol Rep 2012;14(3):293-8
   PubMedGoogle Scholar
• Drakos SG, Wever-Pinzon O, Selzman CH, et al. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol 2013;61(19):1985-94
   PubMed Web of Science ®Google Scholar
• Boehmer JP, Starling RC, Cooper LT, et al. Left ventricular assist device support and. myocardial recovery in recent onset cardiomyopathy. J Card Fail 2012;18(10):755-61
   PubMedGoogle Scholar
• Morgan JA, Brewer RJ, Nemeh HW, et al. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation. ASAIO J 58(6):574-7
   PubMedGoogle Scholar
• Simon MA, Primack BA, Teuteberg J, et al. Left ventricular remodeling and myocardial recovery on mechanical circulatory support. J Card Fail 2010;16(2):99-105
   PubMed Web of Science ®Google Scholar
• Dandel M, Weng Y, Siniawski H, et al. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation 2012;126(11 Suppl 1):S9-19
   Google Scholar
• Ambardekar AV, Walker JS, Walker LA, et al. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail 2011;4(4):425-32
   PubMedGoogle Scholar
• Drakos SG, Kfoury AG, Selzman CH, et al. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol 2011;26(3):245-55
   PubMedGoogle Scholar
• Hall JL, Fermin DR, Birks EJ, et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol 2011;57(6):641-52
   PubMed Web of Science ®Google Scholar
• Koitabashi N, Kass DA. Reverse remodeling in heart failure--mechanisms and therapeutic opportunities. Nat Rev Cardiol 2012;9(3):147-57
   Google Scholar
• Abraham WT, Smith SA. Devices in the management of advanced, chronic heart failure. Nat Rev Cardiol 2013;10(2):98-110
   PubMedGoogle Scholar
• Moazami N, Hoercher KJ, Fukamachi K, et al. Mechanical circulatory support for heart failure: past, present and a look at the future. Expert Rev Med Devices 2013;10(1):55-71
   PubMed Web of Science ®Google Scholar
• Birks EJ, George RS. Molecular changes occurring during reverse remodelling following left ventricular assist device support. J Cardiovasc Transl Res 2010;3(6):635-42
   PubMedGoogle Scholar
• Lompré A-M, Hajjar RJ, Harding SE, et al. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 2010;121(6):822-30
   PubMedGoogle Scholar
• Jessup M, Greenberg B, Mancini D, et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011;124(3):304-13
   PubMed Web of Science ®Google Scholar
• Triposkiadis F, Karayannis G, Giamouzis G, et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009;54(19):1747-62
   PubMed Web of Science ®Google Scholar
• Spinale FG, Zile MR. Integrating the myocardial matrix into heart failure recognition and management. Circ Res 2013;113(6):725-38
   PubMed Web of Science ®Google Scholar
• Saito S, Matsumiya G, Sakaguchi T, et al. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist. J Heart Lung Transplant 2010;29(6):672-9
   PubMedGoogle Scholar
• Felkin LE, Lara-Pezzi E, George R, et al. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support. J Heart Lung Transplant 2009;28(2):117-22
   PubMedGoogle Scholar
• Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 2013;113(6):709-24
   PubMed Web of Science ®Google Scholar
• Chokshi A, Drosatos K, Cheema FH, et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 2012;125(23):2844-53
   PubMed Web of Science ®Google Scholar
• Khan RS, Kato TS, Chokshi A, et al. Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail 2012;5(3):340-8
   PubMedGoogle Scholar
• Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 2011;16(1):13-21
   PubMed Web of Science ®Google Scholar
• De Weger RA, Schipper MEI, Siera-de Koning E, et al. Proteomic profiling of the human failing heart after left ventricular assist device support. J Heart Lung Transplant 2011;30(5):497-506
   PubMedGoogle Scholar
• Matkovich SJ, Van Booven DJ, Youker KA, et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009;119(9):1263-71
   PubMed Web of Science ®Google Scholar
• Ramani R, Vela D, Segura A, et al. A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol 2011;58(22):2270-8
   PubMed Web of Science ®Google Scholar
• Ibrahim M, Yacoub MH. Bridge to recovery and weaning protocols. Heart Fail Clin 2014(10(1 Suppl):S47-55
   Google Scholar
• Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62(3):675-81. discussion 681 -2
   PubMed Web of Science ®Google Scholar
• Levin HR, Oz MC, Catanese KA, et al. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant 1996;15(8):840-2
   PubMedGoogle Scholar
• Malliaras KG, Terrovitis JV, Drakos SG, Nanas JN. Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. J Cardiovasc Transl Res 2009;2(1):114-25
   PubMedGoogle Scholar
• Goldstein DJ, Maybaum S, MacGillivray TE, et al. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail 2012;18(5):392-5
   PubMedGoogle Scholar
• Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011;123(4):381-90
   PubMedGoogle Scholar
• Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115(19):2497-505
   PubMed Web of Science ®Google Scholar
• Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355(18):1873-84
   PubMedGoogle Scholar
• Remission from Stage D Heart Failure - ClinicalTrials.gov. Available from: http://clinicaltrials.gov/ct2/show/NCT01774656?term=nct01774656&rank=1
   Google Scholar
• Ohnishi S, Ohgushi H, Kitamura S, Nagaya N. Mesenchymal Stem Cells for the Treatment of Heart Failure. Int J Hematol 2007;86(1):17-21
   PubMed Web of Science ®Google Scholar
• The evaluation of VAD InterVEntion before inotropic therapy (REVIVE-IT)- ClinicalTrials.gov. Available from: http://clinicaltrials.gov/ct2/show/NCT01369407?term=nct01369407&rank=1
   Google Scholar
• Lamarche Y, Kearns M, Josan K, et al. Successful weaning and explantation of the Heartmate II left ventricular assist device. Can J Cardiol 2011;27(3):358-62
   PubMedGoogle Scholar
• Levin HR, Oz MC, Catanese KA, et al. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant 1996;15(8):840-2
   PubMedGoogle Scholar
• Müller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96(2):542-9
   PubMed Web of Science ®Google Scholar
• Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98(22):2383-9
   PubMed Web of Science ®Google Scholar
• Sun BC, Catanese KA, Spanier TB, et al. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 1999;68(2):688-94
   PubMedGoogle Scholar
• Helman DN, Maybaum SW, Morales DL, et al. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable?. Ann Thorac Surg 2000;70(4):1255-8
   PubMedGoogle Scholar
• Ueno T, Bergin P, Richardson M, Esmore DS. Bridge to recovery with a left ventricular assist device for fulminant acute myocarditis. Ann Thorac Surg 2000;69(1):284-6
   PubMedGoogle Scholar
• Hetzer R, Müller JH, Weng Y, et al. Bridging-to-recovery. Ann Thorac Surg 2001;71(3 Suppl):S109-13; discussion S114–115
   Google Scholar
• El-Banayosy A, Arusoglu L, Kizner L, et al. Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 2001;20(2):209-10
   Google Scholar
• Bruckner BA, Stetson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001;20(4):457-64
   PubMed Web of Science ®Google Scholar
• Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21(5):516-21
   PubMed Web of Science ®Google Scholar
• Khan T, Delgado RM, Radovancevic B, et al. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 2003;22(2):137-46
   PubMedGoogle Scholar
• Gorcsan J 3rd, Severyn D, Murali S, Kormos RL. Non-invasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal. J Heart Lung Transplant 2003;22(12):1304-13
   PubMedGoogle Scholar
• Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005;112(9 Suppl):I37-45
   Google Scholar
• Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005;112(9 Suppl):I32-6
   PubMed Web of Science ®Google Scholar
• Matsumiya G, Monta O, Fukushima N, et al. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?. J Thorac Cardiovasc Surg 2005;130(3):699-704
   PubMedGoogle Scholar
• Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355(18):1873-84
   PubMedGoogle Scholar
• George I, Xydas S, Mancini DM, et al. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant 2006;25(9):1084-90
   PubMedGoogle Scholar
• Liden H, Karason K, Bergh C-H, et al. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery. Eur J Heart Fail 2007;9(5):525-30
   PubMedGoogle Scholar
• Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115(19):2497-505
   PubMed Web of Science ®Google Scholar
• Klotz S, Jan Danser AH, Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008;97(2-3):479-96
   PubMedGoogle Scholar
• Dandel M, Weng Y, Siniawski H, et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008;118(14 Suppl):S94-105
   PubMed Web of Science ®Google Scholar
• Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011;123(4):381-90
   PubMedGoogle Scholar
• Lamarche Y, Kearns M, Josan K, et al. Successful weaning and explantation of the Heartmate II left ventricular assist device. Can J Cardiol 2011;27(3):358-62
   PubMedGoogle Scholar
• Kinoshita O, Kimura M. Kashiwa K, et al. Mid-long term result of implantable ventricular assist device treatment for end-stage heart failure in the University of Tokyo Hospital. Kyobu Geka 2013;66(1):51-6
   PubMedGoogle Scholar
• Patel SR, Saeed O, Murthy S, et al. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study. J Heart Lung Transplant 2013;32(3):305-12
   PubMedGoogle Scholar
• Yagdi T, Oguz E, Engin C, et al. Changing face of heart failure surgery. Transplant Proc 2012;44(6):1729-31
   PubMedGoogle Scholar
• Nasir A, Bonde P, Graham ANJ. Ventricular assist device therapy in post-cardiotomy cardiogenic shock: historical outcomes and current trends. Interact Cardiovasc Thorac Surg 2012;14(5):585-7
   PubMedGoogle Scholar